TABLE 1.
Group | Pat ID | Age | Gender | Diagnosis | Operation | POD | PRBC storage duration (d) | PRBCs transfused during surgery (n) | Total PRBCs at ICU (n) |
---|---|---|---|---|---|---|---|---|---|
Aorta | 34 | 65 | m | Peripheral arterial vascular disease | Axillofemoral bypass | 1 | 11 | 2 | 2 |
36 | 77 | m | Abdominal aortic aneurysm | Bifemoral prothesis | 2 | 24 | 0 | 2 | |
48 | 82 | f | Abdominal aortic aneurysm | Bi-iliacal prothesis | 1 | 17 | 3 | 4 | |
81 | 81 | m | Abdominal aortic aneurysm | Aortic replacement | 2 | 29 | 1 | 4 | |
LuTx | 10 | 65 | m | Fibrosis | LuTx | 3 | 25 | 5 | 34 |
12 | 32 | f | Idiopathic pulmonary hypertension | LuTx | 1 | 23 | 9 | 6 | |
14 | 59 | f | Chronic obstructive pulmonary disease | LuTx | 3 | 36 | 2 | 1 | |
15 | 38 | m | Cystic fibrosis, transplant dysfunction | Re-LuTx | 3 | 31 | 7 | 2 | |
25 | 25 | f | Cystic fibrosis | LuTx | 3 | 29 | 10 | 1 | |
49 | 48 | m | Cystic fibrosis, transplant dysfunction | Re-LuTx | 8 | 18 | 22 | 5 | |
64 | 37 | m | Fibrosis | LuTx | 6 | 23 | 17 | 5 | |
73 | 33 | m | Cystic fibrosis | LuTx | 3 | 20 | 5 | 2 | |
Comparison | 17 | 36 | m | Abdominal wall seroma | Multiple | 5 | 22 | 7 | 6 |
20 | 84 | m | Neoplasma vesicae | Cystectomy | 3 | 25 | 0 | 1 | |
43 | 56 | m | Pericardial effusion | Pericardial drainage | 4 | 33 | 0 | 17 | |
46 | 77 | m | Status post subhepatic hematoma | Wound management | 1 | 29 | 0 | 6 | |
61 | 59 | m | Thymoma | Thymectomy | 44 | 18 | 13 | 20 | |
68 | 59 | m | Renal cell carcinoma | Partial nephrectomy | 1 | 17 | 3 | 5 | |
79 | 72 | f | Stomach perforation | Gastrectomy | 1 | 13 | 1 | 1 | |
80 | 62 | m | Neoplasma vesicae | Cystectomy | 1 | 25 | 0 | 2 | |
87 | 59 | m | Peripheral arterial vascular disease | Thrombectomy | 2 | 20 | 0 | 3 |
Pat ID, patient identification number; PRBC, packed red blood cell; POD, postoperative day at time point of transfusion; d, days; ICU, intensive care unit; LuTx, bilateral lung transplantation; Re-LuTx; repeated bilateral lung transplantation; m, male; f, female.